Atlas Trials

Role of Bumetanide in Treatment of Autism

Clinical trial NCT04766177 · RECRUITING

Trial details

NCT number
NCT04766177
Sponsor
Sherief Abd-Elsalam
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Autism
Start date
2021-01-01
Primary completion
2030-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.